Top 50 Biotech Angel Investors in April 2025

Investor	Biotech investments
Jonathan Milner	35
Milad Alucozai	22
Jeff Dean	13
Jude Gomila	12
Jaffray Woodriff	10
Paul Buchheit	10
Jim Mellon	9
bumpkins profile	9
Kingsley Advani	9
Alice Zhang	8
Jeff Hammerbacher	7
Sahin Boydas	7
Sam Altman	7
Bradley Horowitz	7
Chris Gibson	7
Balaji Srinivasan	7
Wei Guo	7
Bill Gates	6
Zach Weinberg	6
Stefano Bernardi	6
Nadav Rosenberg	6
Evan Cheng	6
Cory Levy	5
Sake Bosch	5
Charlie Songhurst	5
Kevin Moore	5
Erik Peterson	5
Farzad (Zod) Nazem	5
Jan Hammer	5
Bhavik Bajaj	5
Mark Cuban	5
Daniel Curran	5
Anne Wojcicki	5
Brian Armstrong	5
Peter Thiel	5
Elad Gil	5
Arda Kara	4
Daren Cotter	4
Max Levchin	4
Ethan Oren Perlstein	4
Darrin Disley	4
Andrea Dusi	4
Penny Schiffer	4
Annie Vereecken	4
Eric Kwan	4
Benjamin Kong	4
Todd Corenson	4
Brenton Saunders	4
Xavier Niel	4
Ian Hogarth	4

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Spain

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
Epitopea — Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. Cryptigen™ TSAs are discovered by a proprietary approach deploying immunopetidomics, mass spectrometry, genomics, andbioinformatics, which allows the identification of conserved, aberrantly-expressed, tumour-specific antigens, hidden in cancer's 'junk' DNA. These hidden Cryptigen™ TSAs have been identified by research led by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at Université de Montréal.
Exciting Instruments — Exciting Instruments Limited is a joint company founded in Sheffield that combines the software prowess of Bulldozer Limited with Dr. Timothy Craggs' knowledge of single molecules. Through the use of cloud connectivity and real-time data visualisation, we are a genuine science and software partnership on a mission to assist you in streamliningthe procedure for creating discoveries in biophysics, life sciences, drug discovery, and medical diagnostics.

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.

Jeff Dean joined Google in 1999 and is currently a Google Senior Fellow in Google's Research Group, where he leads the Google Brain team, Google's deep learning research team in Mountain View, working on systems for speech recognition, computer vision, language understanding, and various predictive tasks. He has co-designed /implemented five generations of Google's crawling, indexing, and query serving systems, and co-designed / implemented major pieces of Google's initial advertising and AdSense for Content systems. He is also a codesigner and coimplementor of Google's distributed computing infrastructure, including the MapReduce, BigTable and Spanner systems, protocol buffers, LevelDB, and TensorFlow, a popular open-source system for machine learning.Jeff received a Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the Mark Weiser Award and the ACM-Infosys Foundation Award in the Computing Sciences.

Investment focus

Artificial Intelligence, Biotechnology, Information Technology
Seed, Series A, Pre-Seed
United States, Japan, Australia

Portfolio highlights

OpenInfer — OpenInfer develops an AI inference engine for edge applications
Workhelix — Workhelix is a developer of workforce management platform to assist with business management.
Yutori — Yutori is part of a slew of AI startups creating autonomous agents, or systems that use AI to perform actions on their own.

Jude Gomila is currently CEO and Founder of the startup Golden.

Investment focus

Software, Biotechnology, Information Technology
Seed, Pre-Seed, Angel
United States, United Kingdom, Canada

Portfolio highlights

Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!

Angel Investor located in Charlottesville, VA

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Angel
United States

Portfolio highlights

Yogi — Yogi's analytics platform lets you easily sift through customer Reviews & Ratings data. Get actionable insights from your product Reviews, Ratings, and Sentiment Analysis to improve your brand reputation and product experiences.
Caju AI — Caju AI revolutionizes customer engagement with Generative AI, boosting your workforce's productivity and providing invaluable business insights. Elevate your customer experience with the power of AI.
Starchive — AI enriched Digital Asset Management designed by creators for creators, to maximize the control and ownership of their content, community, and commerce in the Visual Media Economy.

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — SiPhox Health brings comprehensive, at-home blood testing to your door! Take control of your disease risk and increase your healthspan today with affordable, convenient at-home blood testing. No lab visits, no appointments, no waiting in line.
Character.ai — Chat with millions of AI Characters anytime, anywhere. Super-intelligent chat bots that hear you, understand you, and remember you. Free to use with no ads.
Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Investment focus

Biotechnology, Food and Beverage, Health Care
Series A, Seed, Funding Round
United States, United Kingdom, Germany

Portfolio highlights

Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement

Kingsley Advani is a British investor. He started investing in 2013, funding 50 companies, 4 funds and donating to non-profits including: SENS Foundation, Methuselah Foundation, Stanford University, National University of Singapore. He is particularly interested in regenerative medicine for age-related disease. Investments: Oisin, Turn Bio,Oncosenx, Monzo, Robinhood, Abra, Coinbase, Momentus, Demonpores, 64-x, Nectome. Investment areas: biotechnology, neurotechnology, longevity, space, fintech.

Investment focus

FinTech, Financial Services, Biotechnology
Seed, Pre-Seed, Series A
United States, Singapore, United Kingdom

Portfolio highlights

Checkstep — AI Content Moderation Services: learn how AI can help you scale your content moderation and keep your users and moderators safe.
Allocations — 10,000+ investors and fund managers build, onboard and close funds on Allocations - the fastest and most advanced fund platform in the world
Ashvattha Therapeutics — Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, United Kingdom

Portfolio highlights

Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.

Jeff Hammerbacher - Partner & Co-Founder @ Techammer

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Series A, Angel
United States

Portfolio highlights

Modal Labs — Modal develops machine learning software to help run code in the cloud. The software enables users to run or deploy machine learning models, massively parallel compute jobs, task queues, web apps, and more. It also writes the code to launch hundreds of custom containers and runs scripts in the cloud faster than on the local machine.
Potato AI — A literature-based research assistant to plan, collaborate on, and run reproducible protocols.
All Hands AI — All Hands AI operates as an open source agent for developers.

Sahin Boydas is the founder of Stealth AI Startup. He previously served as the Head of Turkiye, Distributed Teams, Bootcamp, and App Ecosystem at Gusto. He attended Koç University.

Investment focus

Software, Financial Services, FinTech
Seed, Series A, Series B
United States, Mexico, Spain

Portfolio highlights

CapStack Technologies — Discover Capstack, the leading bank-to-bank marketplace driving banking digital transformation. Join the innovation wave and transform your banking experience now!
Sully.ai — Sully is deploying autonomous medical workers into healthcare organizations to address the most expensive line item in healthcare: payroll ($800b/yr in the US alone). Today, Sully's autonomous workers can perform most medical staff tasks 100x faster and 20x cheaper. From Digital Triage Nurses and Autonomous Medical Assistants to DigitalScribes and Digital Receptionists, our workers can automate patient check-in, assessments, documentation, diagnosis support, and billing that integrates with Electronic Health Records (EHRs)
Biostate AI — Biostate AI develops generative AI that benefit all human health.

Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator from 2016 through 2019. Sam Altman attended Stanford University.

Investment focus

Software, Artificial Intelligence, Internet
Seed, Series A, Series B
United States, Canada, Ghana

Portfolio highlights

Campus — Live courses with top professors.
Helion Energy — Enabling a future with unlimited clean energy
Retro Biosciences — Our mission is to extend healthy human lifespan by 10 years.

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
United States, United Kingdom, Germany

Portfolio highlights

Mill — Mill is the smartest device in your kitchen. Mill turns would-be food waste into resources for the Earth. Keep filling it for weeks.
Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
Overture Life — We are making In Vitro Fertilization (IVF) more accessible than ever before while improving success rates. An embryology lab in a box.

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Seed
United States, France, Switzerland

Portfolio highlights

Amenities Health — Boost revenue and foster patient loyalty with our turnkey membership platform, offering an exceptional digital experience that keeps patients engaged and drives growth.
Cradle — Design better proteins
Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.

Investment focus

Blockchain, Cryptocurrency, Software
Seed, Pre-Seed, Series A
United States, India, Singapore

Portfolio highlights

The Arena — Arena. social is a cutting-edge SocialFi platform that is revolutionizing how content producers interact, network, and make money from their work.
Lica World — Hire Lica, AI Video Producer for Product, Sales, And Customer Success Teams
OpenGradient — OpenGradient is a leading decentralized AI platform for open-source model hosting, secure inference, agentic reasoning, and application deployment. By developing tooling and a feature-rich platform that makes developing AI workflows both secure and seamless, OpenGradient empowers developers with the ability to build in its ecosystem of intelligentand optimized AI-empowered applications. With native model hosting, permissionless composability, and secure inference execution, OpenGradient also aims to accelerate open-source AI by democratizing model ownership, improving verifiability guarantees, and promoting censorship-resistant model access.Our heterogeneous AI compute architecture (HACA) and our proprietary library NeuroML scale secure AI workflows with features like inference, agentic reasoning, statistical analysis, and more. OpenGradient also accelerates open-source innovation with a web portal and SDK for Web2 developers to leverage our AI stack without navigating blockchain complexities, while enjoying the security and composability benefits of decentralized infrastructure.

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Playbook — Playbook gives creators the opportunity to build and grow a subscription business. Fans get an all-access pass to a curated health and wellness content.
Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Investment focus

Energy, Biotechnology, Manufacturing
Series C, Series A, Series B
United States, Canada, Israel

Portfolio highlights

Heineken — Welcome to the global website for Heineken International. Find information about our company, history, brands, strategy and careers here.
Inflection AI — Inflection AI is a machine learning startup that engages in redefining human-computer interaction.
Lucy Therapeutics — Lucy Therapeutics, a Boston-based biotech with a unifying mitochondrial platform, is developing small molecule treatments for neurological diseases.

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Investment focus

Health Care, Software, SaaS
Seed, Series A, Pre-Seed
United States, Israel, United Kingdom

Portfolio highlights

Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Investment focus

Biotechnology, Software, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, Italy, France

Portfolio highlights

Freatic — Building the monetization layer for your alpha
CaSRevolution — A novel disease-modifying approach against neurodegeneration
Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Investment focus

Biotechnology, Artificial Intelligence, Pharmaceutical
Seed, Pre-Seed, Series A
United Kingdom, Israel, Singapore

Portfolio highlights

thymia — Making mental health as objectively measurable as physical health.
Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Loops — With Loops causal insights you can identify your biggest opportunities to maximize your KPIs... try the Loops way

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Pre-Seed, Funding Round
United States, United Kingdom, Australia

Portfolio highlights

PARSIQ — Explore the future of blockchain with PARSIQ - Your gateway to advanced blockchain monitoring, smart triggers, and real-time intelligence. Empower your crypto journey with cutting-edge technology and unparalleled insights. Join us in revolutionizing the way you interact with the blockchain ecosystem
PIN AI — PIN AI democratizes personal on-device intelligence for everyone; transform your digital footprints into your Personal Executive Assistant.
Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.

Cory Levy is the Founder Advisor of Humaning.

Investment focus

Software, Artificial Intelligence, Information Technology
Pre-Seed, Seed, Series A
United States, Canada, India

Portfolio highlights

Lingopal — SaaS API Layer for translation
Omen AI — Harness the power of Ai and proprietary sensing to prevent equipment failures.
Butler — Streamline your workflow with AI-powered summaries, contextual chat, a native meeting bot and more, all in one place.

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

Investment focus

Software, E-Commerce, Biotechnology
Seed, Series A, Series B
The Netherlands, France, Israel

Portfolio highlights

Faircraft — A sustainable, lab-grown alternative to animal leather.
FononTech — FononTech specializes in impulse printing.It is used to print small electronic circuits for electronic devices.
Mermade Seafoods — Mermade is a pioneering cellular aquaculture company, bringing a novel approach and mindset for the production of cell based seafood.

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Germany

Portfolio highlights

FlyMy.AI — Real-time AI cloud
Lovable — Build software products, using only a chat interface
Briefcase — Briefcase automates the legwork in accounting so you can focus on growing your practice

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Investment focus

Software, Health Care, E-Commerce
Seed, Pre-Seed, Angel
United States, India, Canada

Portfolio highlights

Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Augmend — Create documentation and an AI assistant from any video.

Erik Peterson is the Founder at DormTrader.

Investment focus

Software, Biotechnology, SaaS
Seed, Equity Crowdfunding, Series A
United States, Canada, Algeria

Portfolio highlights

Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.

Investment focus

Health Care, Analytics, Machine Learning
Seed, Series A, Series B
United States, Canada

Portfolio highlights

Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
Ceevra — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
TigerGraph — TigerGraph is a scalable graph analytics platform for big data, AI, and machine learning, enabling deep insights and complex relationship exploration.

Jan joined Index in 2010, and is a London-based partner, focusing on fintech and information/data services across all stages of growth.He is one of Index Ventures’ leading fintech investors, working with the founders of Adyen, Credit Benchmark, Robinhood and TransferWise. In all, Index has backed more than two dozen fintech companies, withmore than $400 million. Jan has also led Index investments and is on the boards of Beamery, Collibra, SafetyCulture and Silverfin.Before he joined Index, Jan was at General Atlantic in London, where he worked on investments in Kaspersky Lab, Northgate Information Solutions and Torex Retail. He also worked in the M&A, TMT and Capital Markets divisions at Morgan Stanley. Jan is a graduate of Oxford University, and holds an MBA with Distinction from INSEAD.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China, United States, United Kingdom

Portfolio highlights

MacroLux — MacroLux operates as a medical technology company focusing on endoscopic interventional business. MacroLux develops endoscopic interventional therapy solutions and promote them to the majority of medical customers.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.

Bhavik Bajaj

Investment focus

Information Technology, Software, FinTech
Pre-Seed, Seed, Angel
United States, United Kingdom, Switzerland

Portfolio highlights

Asepha — Asepha is an AI clinical decision support (CDS) tool to help healthcare professionals make faster clinical decisions.
ORA Technologies — E-Commerce, Super App
THIRUMALS PAPER ARIZONA PVT. LTD. — TRADING PLATFORM OF PULP , PAPER & PACKAGING

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Investment focus

Software, Artificial Intelligence, Blockchain
Seed, Series A, Angel
United States, United Kingdom, Singapore

Portfolio highlights

Fetii — Fetii is a group-centric rideshare app that allows groups to ride together using our network of 15-passenger transit vans for about $5 per person on average, thus enhancing the transportation experience while reducing unnecessary vehicles off of the roads.
Remento — A science-backed app to capture family stories through conversation.
Duzter Hockey — Duzter offers a wide range of cut resistant hockey protective equipment to keep players safe on the ice. We have everything you need to stay protected while training or playing.

Daniel Curran is the Founder and CEO at CustEx.com.

Investment focus

E-Commerce, Software, Internet
Seed, Series A, Series B
United States, Canada, Brazil

Portfolio highlights

CARD.com — Fully featured bank account with optional overdraft protection and round up savings account. Get your paycheck up to 2 days earlier.
RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
GC Plus — Find Your Next Home Service Expert With Ease

Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Series B
United States, United Kingdom, Canada

Portfolio highlights

World Labs — World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities.
Solace — Connect with expert patient advocates who can help you navigate the healthcare system and solve any medical problem, no matter what you need.
Endo Health — Reverse Your Diabetes With a Game

Brian Armstrong is the CEO and Co-Founder of Coinbase. He previously worked at Airbnb.com as a Technical Product Manager. Brian Armstrong attended Rice University.

Investment focus

Payments, Financial Services, Banking
Seed, Series A, Series B
United States, Brazil

Portfolio highlights

Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.

Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.

Investment focus

Software, FinTech, Financial Services
Series A, Seed, Series B
United States, Germany, Canada

Portfolio highlights

Hebbia — Hebbia's neural search lets you execute research 10X faster and 10X more accurately. Transform your productivity today.
Mercor — Mercor is a better way to hire. We're an AI-powered platform that sources, vets, and pays your next team members.
Plasma — Plasma is an operational setting that supports payments, real-world assets, and DeFi, with trustless settlement on Bitcoin.

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Series B
United States, United Kingdom, Israel

Portfolio highlights

Quanta — Quanta provides software companies with real-time financial clarity and empowerment. Quanta envision a world in which all business accounting tasks that are not creative in nature are automated, leaving finance teams and business owners to focus solely on strategic and creative work.
Yutori — Yutori is part of a slew of AI startups creating autonomous agents, or systems that use AI to perform actions on their own.
Cognition — Cognition is an applied artificial intelligence lab that focuses on reasoning and code.

Arda Kara

Investment focus

Health Care, Medical, Software
Series A, Seed, Series B
United States, Germany, Switzerland

Portfolio highlights

Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)
Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.

Daren was the Founder and CEO of InboxDollars, an online marketing company that connects consumers and advertisers in a way that benefits both. He founded the company as a Freshman in college in 2000 and bootstrapped the company to more than $25 million in annual revenues. InboxDollars was acquired by Prodege in 2019. Daren is active in the MNstart-up community as an investor, advisor and mentor.

Investment focus

Software, E-Commerce, Health Care
Seed, Series A, Funding Round
United States

Portfolio highlights

Delfina — Intelligent pregnancy care for healthier moms and babies.
Continuum — Simplify B2B returns, warranties, and repairs with Continuum; the only Returns Management Software designed for distributors and manufacturers.
Pakal Technologies — Pakal Technologies is a developer of IGTO-based semiconductors intended to revolutionize the IGBT market. The company's semiconductors use IGTO, a silicon device, that is a drop-in replacement for IGBTs and provides a significant performance upgrade, providing clients with efficient, scalable, and compatible semiconductors.

Max Levchin is the Founder and CEO of Affirm. He previously worked at the Consumer Financial Protection Bureau as an Advisory Board Member. Max Levchin attended the University of Illinois Urbana-Champaign.

Investment focus

FinTech, Financial Services, Internet
Series A, Seed, Series B
United States, United Kingdom, India

Portfolio highlights

Bland AI — Transform your enterprise communication with Bland AI. Automate inbound and outbound phone calls using AI that sounds human. Perfect for sales, customer support, and operations with customizable voices and seamless integrations.
CoPilot — CoPilot is pioneering Assisted Commerce for big-ticket purchases – starting with cars. You are the one spending the money - shouldn't you have an expert on your side? We founded CoPilot to make that a reality. For the average car buyer, who is not a car expert or enthusiast, car shopping can be a time consuming, frustrating process that leavespeople feeling alone and disadvantaged. CoPilot is changing this dynamic. Like a trusted friend who is knowledgeable about cars, knows where to look and what to buy, CoPilot provides car shoppers with an expert partner who empowers them to discover the perfect car at the best possible price with ease and confidence.
Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.

Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.

Investment focus

Biotechnology, Cannabis, Biopharma
Seed
United States, Canada

Portfolio highlights

Epinoma — Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California.
BluumBio — BluumBio develops next-generation remediation technologies that clean up pollution and restore degraded ecosystems
Promakhos Therapeutics — A Boston-based biotech startup developing therapeutics.

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Investment focus

Biotechnology, Health Care, Big Data
Seed, Series A, Funding Round
United Kingdom

Portfolio highlights

bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.

Entrepreneur and investor. After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded Impactscool.He is advisor of dozens oftechnological initiatives and business angels in 150+ startups focusing on clean tech.He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018.

Investment focus

Biotechnology, Health Care, Information Technology
Seed, Pre-Seed, Series A
Italy, United States, United Kingdom

Portfolio highlights

Talyn Air — Inspired by two-stage rockets, our innovative eVTOL uses two flight vehicles to transform flight. Fixed-wing performance with VTOL capabilities.
BillionToOne — We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.
CaSRevolution — A novel disease-modifying approach against neurodegeneration

Penny Schiffer - CEO & Co-founder @ Raized.ai

Investment focus

Health Care, Medical, Finance
Funding Round, Seed, Series A
Switzerland, Germany, United Kingdom

Portfolio highlights

Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.

Annie Vereecken

Investment focus

Biotechnology, Medical, Hospital
Seed, Series A, Funding Round
Belgium

Portfolio highlights

Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).

Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures

Investment focus

Software, FinTech, E-Commerce
Seed, Pre-Seed, Funding Round
United States, India, Canada

Portfolio highlights

Treinta — Treinta is a digital ledger app for Latin American microbusinesses. Through Treinta, users can easily record transactions by assigning products from their inventory and see how their business metrics evolve in real time. The app helps owners save up to 30 minutes a day in bookkeeping related tasks and improve efficiency by over 30%. Out of the 50million microbusinesses in LATAM, today 90% still track their sales and expenses by using pen and paper.
Ferveret — Ferveret develops liquid cooling technology for data centers and other infrastructure. Our company is backed by Y Combinator and MIT Media Lab's E14.
Kriya AI is now Kalendar AI — Kalendar AI books new revenue on autopilot

Benjamin Kong is a Canadian investor backing early-stage transformative startups in Space, Biotech, Life Sciences, AI, Longevity, and Blockchain. He started investing in 2014 and has since funded over 50 startups and 3 VC funds. Recent early stage investments include Luminous Computing, Orbit Fab, Relativity Space, Swarm, TransAstra, RadianAerospace, Volumetric, OISIN, OncoSenX, Aegis BioDefense, Excision Biotherapeutics, MAIA Biotechnology, Ashvattha Therapeutics, ZenGo, Coinbase, Algorand, Oasis Labs, Arweave.

Investment focus

Blockchain, Biotechnology, Cryptocurrency
Seed, Pre-Seed, Funding Round
United States, Israel, United Kingdom

Portfolio highlights

Radian — Radian Aerospace (Radian) is disrupting the aerospace industry with a next generation aerospace vehicle that is the world’s first fully reusable horizontal takeoff and landing, single-stage to orbit spaceplane, delivering people and light cargo to low earth orbit (LEO) and multiple terrestrial destinations with aircraft-like operations.
Volumetric — Advanced materials and 3D biofabrication.
Excision BioTherapeutics — Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Todd Corenson - Founder @ Enlon

Investment focus

Biotechnology, FinTech, SaaS
Seed, Pre-Seed, Convertible Note
United States

Portfolio highlights

Solugen — Solugen's mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale.Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with thecompetition.
HelixNano — Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
iMicrobes — We are a synthetic biology company on the mission to work with the world's largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.

Brenton Saunders is the current Chief Executive Officer of Bausch & Lomb. He previously worked at The Allergan Foundation as a Chairman. Brenton Saunders attended Temple University’s Fox School of Business.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Series B
United States

Portfolio highlights

Wondermind — Welcome to Wondermind, your home for approachable, expert-backed mental health content you can actually use.
Nucleus — Nucleus provides genetic analysis of greater breadth, depth, and beauty. Users can upload their genetic information obtained through an established company. The proprietary algorithms will calculate polygenic risk scores and measure disease risk based on analysis of genetic variants and display them in a user-friendly platform.
Lipidio Pharmaceuticals — A Unique Approach to Treating Obesity Precision Targeting of the Skin Exploiting the skin as an endocrine organ Historically regarded as a protective barrier organ, the skin is now recognized as an active endocrine organ capable of synthesizing, and secreting diverse hormones and signaling

Xavier Niel is the Co-Founder and CEO of NJJ Capital. He previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.

Investment focus

Software, Artificial Intelligence, SaaS
Seed, Series A, Funding Round
France, United States, United Kingdom

Portfolio highlights

Cube — Cube AI boosts back-office logistics efficiency, allowing teams to handle more loads and focus on human relationships.
Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
The Mobile-First Company — Early Stage Startup that is Simplifying Business, One App at a Time. Forget about those overcomplicated, pricey software giants. We're building easy, mobile-first tools that actually make sense.

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Investment focus

Software, E-Commerce, Internet
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
Fabric — A file explorer and workspace for the internet age. Your drives, clouds, notes, screenshots, links and files automatically gathered into one intelligent home. The world's first AI-native universal storage.